FXYD6P2

Across TCGA pan-cancer cohorts, FXYD6P2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of FXYD6P2’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where FXYD6P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FXYD6P2 is over-expressed in tumor.

LUAD and BRCA are the cancer types where FXYD6P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FXYD6P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.073	.011	4	view →
BRCA	All	All	+0.042	.002	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

FXYD6P2–LUAD

Open the LUAD breakdown →